Genetic testing, particularly cancer genomic testing (CGx), continues to be an enforcement target in cases involving telemedicine and beyond. The New Jersey U.S. Attorney’s Office just announced the most recent criminal case involving CGx. On February 4, a criminal complaint in the District of New Jersey was filed against two men alleged to have paid kickbacks and bribes in exchange for referrals of patient DNA samples and genetic tests to Ark Laboratory Network, LLC. The defendants, John Berberian and Christopher Lytle are charged with conspiring to violate the Anti-Kickback Statute. As noted in the complaint, Ark has centered prominently in several other cases involving telemedicine and CGx-related frauds, all of which are profiled in the Case Tracker.
Menu
